Crystallization of trehalose in frozen solutions and its phase behavior during drying.
OBJECTIVE
(i) To study the crystallization of trehalose in frozen solutions and (ii) to understand the phase transitions during the entire freeze-drying cycle.


METHODS
Aqueous trehalose solution was cooled to -40°C in a custom-designed sample holder. The frozen solution was warmed to -18°C and annealed, and then dried in the sample chamber of the diffractometer. XRD patterns were continuously collected during cooling, annealing and drying.


RESULTS
After cooling, hexagonal ice was the only crystalline phase observed. However, upon annealing, crystallization of trehalose dihydrate was evident. Seeding the frozen solution accelerated the solute crystallization. Thus, phase separation of the lyoprotectant was observed in frozen solutions. During drying, dehydration of trehalose dihydrate yielded a substantially amorphous anhydrous trehalose.


CONCLUSIONS
Crystallization of trehalose, as trehalose dihydrate, was observed in frozen solutions. The dehydration of the crystalline trehalose dihydrate to substantially amorphous anhydrate occurred during drying. Therefore, analyzing the final lyophile will not reveal crystallization of the lyoprotectant during freeze-drying. The lyoprotectant crystallization can only become evident by continuous monitoring of the system during the entire freeze-drying cycle. In light of the phase separation of trehalose in frozen solutions, its ability to serve as a lyoprotectant warrants further investigation.
Sundaramurthi
Prakash
P
Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Patapoff
Thomas W
TW
Suryanarayanan
Raj
R
D003460:Crystallization; D005615:Freezing; D012996:Solutions; D014199:Trehalose / Q000737:chemistry*; D014961:X-Ray Diffraction
D012996:Solutions; D014199:Trehalose
Pharm Res. 2005 Feb;22(2):303-9
15783079
J Pharm Sci. 2002 Nov;91(11):2283-300
12379914
Pharm Dev Technol. 2004;9(1):85-95
15000469
Pharm Dev Technol. 1998 Nov;3(4):587-96
9834963
Pharm Res. 2004 May;21(5):867-74
15180347
Pharm Res. 2007 Mar;24(3):593-604
17245648
Arch Biochem Biophys. 1999 May 15;365(2):289-98
10328824
Biophys J. 1996 Oct;71(4):2087-93
8889183
Pharm Res. 2003 May;20(5):802-3
12751637
J Pharm Sci. 1997 Nov;86(11):1198-203
9383725
Int J Pharm. 2008 Nov 3;363(1-2):162-9
18672043
J Phys Chem B. 2010 Apr 15;114(14):4915-23
20302316
Pharm Res. 2004 Jul;21(7):1167-76
15290856
Pharm Res. 1993 Aug;10(8):1232-7
8415413
Pharm Res. 1997 May;14(5):578-90
9165527
Annu Rev Physiol. 1998;60:73-103
9558455
Pharm Biotechnol. 2002;14:47-127
12189730
Pharm Res. 1997 Aug;14(8):969-75
9279875
Pharm Res. 2010 Nov;27(11):2384-93
20824310
J Pharm Sci. 2008 Mar;97(3):1301-12
17683061